Radiation-induced release of transforming growth factor alpha activates the epidermal growth factor receptor and mitogen-activated protein kinase pathway in carcinoma cells, leading to increased proliferation and protection from radiation-induced cell death.

Exposure of A431 squamous and MDA-MB-231 mammary carcinoma cells to ionizing radiation has been associated with short transient increases in epidermal growth factor receptor (EGFR) tyrosine phosphorylation and activation of the mitogen-activated protein kinase (MAPK) and c-Jun NH(2)-terminal kinase (JNK) pathways. Irradiation (2 Gy) of A431 and MDA-MB-231 cells caused immediate primary activations (0-10 min) of the EGFR and the MAPK and JNK pathways, which were surprisingly followed by later prolonged secondary activations (90-240 min). Primary and secondary activation of the EGFR was abolished by molecular inhibition of EGFR function. The primary and secondary activation of the MAPK pathway was abolished by molecular inhibition of either EGFR or Ras function. In contrast, molecular inhibition of EGFR function abolished the secondary but not the primary activation of the JNK pathway. Inhibition of tumor necrosis factor alpha receptor function by use of neutralizing monoclonal antibodies blunted primary activation of the JNK pathway. Addition of a neutralizing monoclonal antibody versus transforming growth factor alpha (TGFalpha) had no effect on the primary activation of either the EGFR or the MAPK and JNK pathways after irradiation but abolished the secondary activation of EGFR, MAPK, and JNK. Irradiation of cells increased pro-TGFalpha cleavage 120-180 min after exposure. In agreement with radiation-induced release of a soluble factor, activation of the EGFR and the MAPK and JNK pathways could be induced in nonirradiated cells by the transfer of media from irradiated cells 120 min after irradiation. The ability of the transferred media to cause MAPK and JNK activation was blocked when media were incubated with a neutralizing antibody to TGFalpha. Thus radiation causes primary and secondary activation of the EGFR and the MAPK and JNK pathways in autocrine-regulated carcinoma cells. Secondary activation of the EGFR and the MAPK and JNK pathways is dependent on radiation-induced cleavage and autocrine action of TGFalpha. Neutralization of TGFalpha function by an anti-TGFalpha antibody or inhibition of MAPK function by MEK1/2 inhibitors (PD98059 and U0126) radiosensitized A431 and MDA-MB-231 cells after irradiation in apoptosis, 3-[4, 5-dimethylthiazol-2-yl]-2,5-diphenyltetrazolium bromide (MTT), and clonogenic assays. These data demonstrate that disruption of the TGFalpha-EGFR-MAPK signaling module represents a strategy to decrease carcinoma cell growth and survival after irradiation.

[1]  J. Minna,et al.  Evaluation of a tetrazolium-based semiautomated colorimetric assay: assessment of radiosensitivity. , 1987, Cancer research.

[2]  P. Hamilton,et al.  Modulation of transforming growth factor alpha‐dependent expression of epidermal growth factor receptor gene by transforming growth factor beta, triiodothyronine, and retinoic acid , 1989, Journal of cellular biochemistry.

[3]  K. Valerie,et al.  Expression of oestrogen receptor and transforming growth factor-alpha in MCF-7 cells after exposure to fractionated irradiation. , 1992, International journal of radiation biology.

[4]  G L Johnson,et al.  Differential activation of ERK and JNK mitogen-activated protein kinases by Raf-1 and MEKK. , 1994, Science.

[5]  G. Prévost,et al.  Evidence for a growth effect of epidermal growth factor on MDA-MB-231 breast cancer cells. , 1994, European journal of cancer.

[6]  K. Valerie,et al.  Host-cell reactivation of reporter genes introduced into cells by adenovirus as a convenient way to measure cellular DNA repair. , 1995, Mutation research.

[7]  Stephen J. Elledge,et al.  Mice Lacking p21 CIP1/WAF1 undergo normal development, but are defective in G1 checkpoint control , 1995, Cell.

[8]  K. Kinzler,et al.  p53-dependent and independent expression of p21 during cell growth, differentiation, and DNA damage. , 1995, Genes & development.

[9]  Michael E. Greenberg,et al.  Opposing Effects of ERK and JNK-p38 MAP Kinases on Apoptosis , 1995, Science.

[10]  G. Johnson,et al.  Fibroblast Growth Factor-2 Suppression of Tumor Necrosis Factor α-Mediated Apoptosis Requires Ras and the Activation of Mitogen-activated Protein Kinase* , 1996, The Journal of Biological Chemistry.

[11]  Seamus J. Martin,et al.  Acid Sphingomyelinase–Deficient Human Lymphoblasts and Mice Are Defective in Radiation-Induced Apoptosis , 1996, Cell.

[12]  E. Adamson,et al.  UV activates growth factor receptors via reactive oxygen intermediates , 1996, The Journal of cell biology.

[13]  J. Baselga,et al.  Autocrine Regulation of Membrane Transforming Growth Factor- Cleavage (*) , 1996, The Journal of Biological Chemistry.

[14]  J. Lunec,et al.  Induction of metalloproteinase (MMP1) expression by epidermal growth factor (EGF) receptor stimulation and serum deprivation in human breast tumour cells. , 1996, European journal of cancer.

[15]  H. Warenius,et al.  Exit from G2 phase after 2 Gy gamma irradiation is faster in radiosensitive human cells with high expression of the RAF1 proto-oncogene. , 1996, Radiation research.

[16]  W. A. Yeudall,et al.  Growth inhibitory concentrations of EGF induce p21 (WAF1/Cip1) and alter cell cycle control in squamous carcinoma cells. , 1996, Oncogene.

[17]  Michael Karin,et al.  Ultraviolet Light and Osmotic Stress: Activation of the JNK Cascade Through Multiple Growth Factor and Cytokine Receptors , 1996, Science.

[18]  M. Shannon,et al.  The effect of ionizing radiation on signal transduction: antibodies to EGF receptor sensitize A431 cells to radiation. , 1996, Biochimica et biophysica acta.

[19]  T. Whiteside,et al.  Activation of Raf by ionizing radiation , 1996, Nature.

[20]  D. McConkey,et al.  Ras signaling in tumor necrosis factor‐induced apoptosis. , 1996, The EMBO journal.

[21]  V. Soldatenkov,et al.  Antisense raf oligodeoxyribonucleotide is protected by liposomal encapsulation and inhibits Raf-1 protein expression in vitro and in vivo: implication for gene therapy of radioresistant cancer , 1997, Gene Therapy.

[22]  M. Shannon,et al.  EGF receptor phosphorylation is affected by ionizing radiation. , 1997, Biochimica et Biophysica Acta.

[23]  J. Mendelsohn,et al.  Epidermal growth factor receptor family and chemosensitization. , 1997, Journal of the National Cancer Institute.

[24]  B. Kavanagh,et al.  Radiation-induced proliferation of the human A431 squamous carcinoma cells is dependent on EGFR tyrosine phosphorylation , 1997, Oncogene.

[25]  P. Dent,et al.  Association of Grb2 with Sos and Ras with Raf-1 upon gamma irradiation of breast cancer cells , 1997, Oncogene.

[26]  E. Lees,et al.  Raf-induced proliferation or cell cycle arrest is determined by the level of Raf activity with arrest mediated by p21Cip1 , 1997, Molecular and cellular biology.

[27]  N. Goldstein,et al.  Neutralizing antibodies against epidermal growth factor and ErbB-2/neu receptor tyrosine kinases down-regulate vascular endothelial growth factor production by tumor cells in vitro and in vivo: angiogenic implications for signal transduction therapy of solid tumors. , 1997, The American journal of pathology.

[28]  A Sewing,et al.  High-intensity Raf signal causes cell cycle arrest mediated by p21Cip1 , 1997, Molecular and cellular biology.

[29]  P. Leder,et al.  Loss of p21 increases sensitivity to ionizing radiation and delays the onset of lymphoma in atm-deficient mice. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[30]  G. Cooper,et al.  Ras links growth factor signaling to the cell cycle machinery via regulation of cyclin D1 and the Cdk inhibitor p27KIP1 , 1997, Molecular and cellular biology.

[31]  J. Baldassare,et al.  Sustained activation of extracellular-signal-regulated kinase 1 (ERK1) is required for the continued expression of cyclin D1 in G1 phase. , 1997, The Biochemical journal.

[32]  K. Ellem,et al.  UVC activation of the HeLa cell membrane “TGFαASE,” a metalloenzyme , 1997 .

[33]  R. Weichselbaum,et al.  Decreasing the apoptotic threshold of tumor cells through protein kinase C inhibition and sphingomyelinase activation increases tumor killing by ionizing radiation. , 1997, Cancer research.

[34]  F. Hobbs,et al.  Identification of a Novel Inhibitor of Mitogen-activated Protein Kinase Kinase* , 1998, The Journal of Biological Chemistry.

[35]  T. Takeuchi,et al.  Correlation of epidermal growth factor receptor and radiosensitivity in human maxillary carcinoma cell lines. , 1998, Acta oto-laryngologica.

[36]  T. Jacks,et al.  Involvement of p53 and p21 in Cellular Defects and Tumorigenesis in Atm−/− Mice , 1998, Molecular and Cellular Biology.

[37]  P. Fisher,et al.  Inhibition of the mitogen activated protein (MAP) kinase cascade potentiates cell killing by low dose ionizing radiation in A431 human squamous carcinoma cells , 1998, Oncogene.

[38]  A. Fornace,et al.  Ultraviolet-irradiation-induced apoptosis is mediated via ligand independent activation of tumor necrosis factor receptor 1 , 1998, Oncogene.

[39]  D Tripathy,et al.  Phase II study of receptor-enhanced chemosensitivity using recombinant humanized anti-p185HER2/neu monoclonal antibody plus cisplatin in patients with HER2/neu-overexpressing metastatic breast cancer refractory to chemotherapy treatment. , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[40]  M. Ewen,et al.  Enforced CDK4 expression in a hematopoietic cell line confers resistance to the G1 arrest induced by ionizing radiation , 1998, Oncogene.

[41]  H. Handa,et al.  Involvement of MAP kinase-independent protein kinase C signaling pathway in the EGF-induced p21(WAF1/Cip1) expression and growth inhibition of A431 cells. , 1998, Biochemical and biophysical research communications.

[42]  R. DePinho,et al.  Prolonged activation of the mitogen-activated protein kinase pathway promotes DNA synthesis in primary hepatocytes from p21Cip-1/WAF1-null mice, but not in hepatocytes from p16INK4a-null mice. , 1998, The Biochemical journal.

[43]  R. Schmidt-Ullrich,et al.  The roles of signaling by the p42/p44 mitogen-activated protein (MAP) kinase pathway; a potential route to radio- and chemo-sensitization of tumor cells resulting in the induction of apoptosis and loss of clonogenicity , 1998, Leukemia.

[44]  R. Schmidt-Ullrich,et al.  Calcium-dependent stimulation of mitogen-activated protein kinase activity in A431 cells by low doses of ionizing radiation. , 1998, Radiation research.

[45]  S. Ménard,et al.  Increased expression of c-erbB-2 in hormone-dependent breast cancer cells inhibits cell growth and induces differentiation , 1998, Oncogene.

[46]  S. Hartman,et al.  Involvement of Ras in Bruton’s Tyrosine Kinase-mediated JNK Activation* , 1998, The Journal of Biological Chemistry.

[47]  L. Pirola,et al.  The Ras/Rac1/Cdc42/SEK/JNK/c-Jun cascade is a key pathway by which agonists stimulate DNA synthesis in primary cultures of rat hepatocytes. , 1998, Molecular biology of the cell.

[48]  P. W. Janes,et al.  Inhibition of the MAP kinase cascade blocks heregulin-induced cell cycle progression in T-47D human breast cancer cells , 1998, Oncogene.

[49]  V. Jordan,et al.  The oestrogen-like effect of 4-hydroxytamoxifen on induction of transforming growth factor alpha mRNA in MDA-MB-231 breast cancer cells stably expressing the oestrogen receptor. , 1998, British Journal of Cancer.

[50]  A. Haimovitz-Friedman.  Radiation-induced signal transduction and stress response. , 1998, Radiation research.

[51]  P. Dent,et al.  The mitogen-activated protein (MAP) kinase cascade can either stimulate or inhibit DNA synthesis in primary cultures of rat hepatocytes depending upon whether its activation is acute/phasic or chronic. , 1998, The Biochemical journal.

[52]  J E Darnell,et al.  Epidermal growth factor-induced growth inhibition requires Stat1 activation. , 1998, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

[53]  M. Silvy,et al.  Differential dose-dependent effects of epidermal growth factor on gene expression in A431 cells: evidence for a signal transduction pathway that can bypass Raf-1 activation. , 1998, Endocrinology.

[54]  L. Norton,et al.  Recombinant humanized anti-HER2 antibody (Herceptin) enhances the antitumor activity of paclitaxel and doxorubicin against HER2/neu overexpressing human breast cancer xenografts. , 1998, Cancer research.

[55]  P. Dent,et al.  Inhibition of the MAPK pathway abrogates BCL2-mediated survival of leukemia cells after exposure to low-dose ionizing radiation. , 1999, Radiation research.

[56]  Derek W. Abbott,et al.  Mitogen-activated Protein Kinase Kinase 2 Activation Is Essential for Progression through the G2/M Checkpoint Arrest in Cells Exposed to Ionizing Radiation* , 1999, The Journal of Biological Chemistry.

[57]  P. Harari,et al.  Epidermal growth factor receptor blockade with C225 modulates proliferation, apoptosis, and radiosensitivity in squamous cell carcinomas of the head and neck. , 1999, Cancer research.

[58]  R. Schmidt-Ullrich,et al.  The inducible expression of dominant-negative epidermal growth factor receptor-CD533 results in radiosensitization of human mammary carcinoma cells. , 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.

[59]  J. Contessa,et al.  Dominant negative EGFR-CD533 and inhibition of MAPK modify JNK1 activation and enhance radiation toxicity of human mammary carcinoma cells , 1999, Oncogene.